All Infectious Disease articles – Page 5
-
NewsEradivir announces Phase 2 human challenge study of EV25 in healthy adults infected with influenza
Eradivir, a clinical-stage small molecule immunotherapy biotech company, announced it has begun a Phase 2 challenge study with its antiviral therapeutic, EV25.
-
NewsFewer than half of parents think they have accurate information about bird flu
Most parents say they don’t know if there have been cases of bird flu in their state, and less than half feel that they are able to find accurate and current information about it, according to a new national US poll.
-
NewsBAADesign enables the immune escaped etesevimab fully-armed against SARS-CoV-2 Omicron subvariants
BAADesign offers a powerful tool for reengineering monoclonal antibodies to combat emerging SARS-CoV-2 variants, providing a scalable solution for future pandemic preparedness, according to a new study.
-
NewsNew biosensor can detect airborne bird flu in under 5 minutes
A new biosensor for monitoring aerosol particles of H5N1 works within five minutes, preserving the sample of the microbes for further analysis and providing a range of the pathogen concentration levels detected on a farm.
-
NewsStudy: Smartwatches could end the next pandemic
Everyday smartwatches are extremely accurate in detecting viral infection long before symptoms appear — new research shows how they could help stop a pandemic before it even begins.
-
NewsThe math behind social distancing: the rules that influence epidemic behavior
Researchers have worked out how to understand social distancing behavior. The team identified simple rules that govern how individuals adapt their behavior during an epidemic in order to balance the costs of infection and social distancing.
-
NewsRecommendations announced for influenza vaccine composition for the 2025-2026 northern hemisphere influenza season
The World Health Organization (WHO) has announced the recommendations for the viral composition of influenza vaccines for the 2025-2026 influenza season in the northern hemisphere.
-
NewsSynthetic microbiome therapy suppresses bacterial infection without antibiotics
A synthetic microbiome therapy, tested in mice, protects against severe symptoms of a gut infection that is notoriously difficult-to-treat and potentially life threatening in humans. Clostridioides difficile is a bacterium that can cause severe diarrhea, abdominal pain and colon inflammation.
-
NewsIsolated population of chlamydia-free koalas even more vulnerable to the disease
Koalas in south-western Sydney are among the very few in New South Wales (NSW) still free of chlamydia, yet a new study shows they are less likely to adapt to the disease should it arrive on their doorstep.
-
NewsFrom dormant to danger: How VZV reactivation is driving CNS infections
Researchers conducted a comprehensive study spanning 10 years (2013–2022), to identify the VZV-related infections affecting the central nervous system. Their study reveals a marked increase in adult VZV-related CNS infections, particularly since 2019.
-
NewsMontana State scientist receives $2.8 million grant to advance Lyme disease research
Funding from the National Institutes of Health will allow a Montana State University research team to deepen explorations into a disease that is posing an increasing threat in the U.S. Lyme disease is a bacterial infection transmitted by ticks.
-
NewsStudy compares indoor transmission-risk metrics for infectious diseases
A recent study delves into the complex world of assessing the transmission risk of infectious diseases in indoor spaces. Understanding how to accurately evaluate the effectiveness of non-pharmaceutical interventions (NPIs) has become crucial.
-
NewsFlu vaccine offers moderate protection against strains dominant in most European countries in 2024/2025
According to interim analysis of influenza vaccine effectiveness for the 2024/2025 season in Europe, the vaccine offered moderate protection against dominant influenza A strains, and strong protection against influenza B.
-
NewsDemocratic Republic of the Congo deepens investigation on cluster of illness and community deaths in Equateur province
Health authorities in the Democratic Republic of the Congo and experts from World Health Organization (WHO) are carrying out further investigations to determine the cause of another cluster of illness and community deaths in Equateur province.
-
NewsImmunity against seasonal H1N1 flu reduces bird flu severity in ferrets, study suggests
Pre-existing immunity against seasonal H1N1 flu might help explain why most reported human cases of H5N1 bird flu in the U.S. have not resulted in lethal outcomes, suggests a new study.
-
NewsBeacon Technology Solutions, Illinois Tech awarded grant to advance far-UVC disinfection research
Beacon Technology Solutions, with collaborators at Illinois Institute of Technology, has been awarded a grant to support a novel study on how Far-UVC technology can help mitigate the spread of infectious diseases in public spaces.
-
NewsNeutrophil-to-lymphocyte ratio and its correlation with tuberculosis infection
A new study reveals a significant negative correlation between neutrophil-to-lymphocyte ratio (NLR) and the risk of tuberculosis infection (TBI), particularly in males and individuals with hypertension.
-
NewsNew paper-based device boosts HIV test accuracy from dried blood samples
Scientists have trialled a more precise medical device to measure HIV viral loads by engineering a paper device with wax-printed patterns that create precise channels and collection spots, ensuring it consistently collects the same volume of blood.
-
NewsAs dengue spreads, researchers discover a clue to fighting the virus
Children who experience multiple cases of dengue virus develop an army of dengue-fighting T cells, according to a new study. Most children who experienced two or more dengue infections showed very minor symptoms—or no symptoms at all—when they caught the virus again.
-
NewsStealth virus: Zika virus builds tunnels to covertly infect cells of the placenta
Researchers have discovered that Zika virus in the placenta builds underground tunnels, a series of tiny tubes called tunneling nanotubes, that facilitate the transfer of viral particles to neighboring uninfected cells.